Recombinant porcine epidermal growth protein (rrhEGF) is gaining increased attention as a promising strategy in the domain of wound therapy. This active molecule, created through genetic technology, offers a https://recombinantporcineegf376646.bloggers-hub.com/61610963/engineered-pig-skin-development-substance-a-powerful-agent-for-wound-regeneration